P
Pacific Biosciences of California, Inc.
PACB · NASDAQ · Healthcare · 357M
Closing price
$2.33
+1.30% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
130.7×
Enterprise value / EBITDAEV/EBITDA
-9.1×
Free cash flow yieldFCF yield
-16.3%
Return on equityROE
-10214.5%
Operating margin
-348.5%
Net debt / EBITDAbalance-sheet strength
-4.6×
Interest coverage
-80.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.